References
- SharmaSVermaATejaBVShuklaPMishraPRDevelopment of stabilized paclitaxel nanocrystals: in-vitro and in-vivo efficacy studiesEur J Pharm Sci201569516025559064
- SzebeniJComplement activation-related pseudoallergy: a new class of drug-induced acute immune toxicityToxicology20052162–310612116140450
- SzebeniJAlvingCRSavaySFormation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactionsInt Immunopharmacol20011472173511357884
- YamashitaSKatsumiHHibinoNDevelopment of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasisBiomaterials2018154748529120820
- JiangXZhangBZhouZEnhancement of radiotherapy efficacy by pleiotropic liposomes encapsulated paclitaxel and perfluorotributylamineDrug Deliv20172411419142828937321
- WuQDuFLuoYPoly(ethylene glycol) shell-sheddable nanomicelle prodrug of camptothecin with enhanced cellular uptakeColloids Surf B Biointerfaces201310529430223384692
- WaisUJacksonAWZuoYXiangYHeTZhangHDrug nanoparticles by emulsion-freeze–drying via the employment of branched block copolymer nanoparticlesJ Control Release201622214115026704935
- ZhouMZhangXYuCNanXChenXZhangXShape regulated anticancer activities and systematic toxicities of drug nanocrystals in vivoNanomedicine201612118118926427356
- DanJMaYYuePMicrocrystalline cellulose-carboxymethyl cellulose sodium as an effective dispersant for drug nanocrystals: a case studyCarbohydr Polym201613649950626572381
- SarnesAKovalainenMHäkkinenMRNanocrystal-based peroral itraconazole delivery: superior in vitro dissolution enhancement versus Sporanox® is not realized in vivo drug absorptionJ Control Release201418010911624566254
- SarnesAØstergaardJJensenSSDissolution study of nanocrystal powders of a poorly soluble drug by UV imaging and channel flow methodsEur J Pharm Sci2013503–451151923999036
- ZhaoZWuCZhaoYHaoYLiuYZhaoWDevelopment of an oral push–pull osmotic pump of fenofibrate-loaded mesoporous silica nanoparticlesInt J Nanomedicine2015101691170125784799
- ZhangZQuanGWuQLoading amorphous Asarone in mesoporous silica SBA-15 through supercritical carbon dioxide technology to enhance dissolution and bioavailabilityEur J Pharm Biopharm201592283125720818
- ZhangCLiCHuangSSelf-activated luminescent and mesoporous strontium hydroxyapatite nanorods for drug deliveryBiomaterials201031123374338320122726
- SrivalliKMMishraBPreparation and pharmacodynamic assessment of ezetimibe nanocrystals: effect of P-gp inhibitory stabilizer on particle size and oral absorptionColloids Surf B Biointerfaces201513575676426342321
- DuJLiXZhaoHNanosuspensions of poorly water-soluble drugs prepared by bottom-up technologiesInt J Pharm2015495273874926383838
- SinhaBMüllerRHMöschwitzerJPSystematic investigation of the caviprecipitation process for the production of ibuprofen nanocrystalsInt J Pharm2013458231532324148667
- ZhaoSCastleGSPAdamiakKFactors affecting deposition in electrostatic pesticide sprayingJ Electrostat200866594601
- PascuzziSCerrutoESpray deposition in “tendone” vineyards when using a pneumatic electrostatic sprayerCrop Prot201568111
- ColbertSACairncrossRAA computer simulation for predicting electrostatic spray coating patternsPowder Technol20051511–37786
- WuYMacKayJAMcDanielJRChilkotiAClarkRLFabrication of elastin-like polypeptide nanoparticles for drug delivery by electrosprayingBiomacromolecules2009101192419072041
- SridharRRamakrishnaSElectrosprayed nanoparticles for drug delivery and pharmaceutical applicationsBiomatter201333pii: e24281
- ZamaniMPrabhakaranMPRamakrishnaSAdvances in drug delivery via electrospun and electrosprayed nanomaterialsInt J Nanomedicine201382997301723976851
- BohrAKristensenJDyasMEdirisingheMStrideERelease profile and characteristics of electrosprayed particles for oral delivery of a practically insoluble drugJ R Soc Interface20129752437244922535697
- YangYYLiuZPYuDGWangKLiuPChenXColon-specific pulsatile drug release provided by electrospun shellac nanocoating on hydrophilic amorphous compositesInt J Nanomedicine2018132395240429713169
- LiuZWangHWangEZhangXYuanRZhuYSuperhydrophobic poly(vinylidene fluoride) membranes with controllable structure and tunable wettability prepared by one-step electrospinningPolymer201682105113
- NymanDWCampbellKJHershEPhase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignanciesJ Clin Oncol200523317785779316258082
- WlodarskiKZhangFLiuTSawickiWKippingTSynergistic effect of polyvinyl alcohol and copovidone in itraconazole amorphous solid dispersionsPharm Res20183511629305665
- WuCSunXZhaoZSynthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugsMater Sci Eng C Mater Biol Appl20144426226725280705
- ZhangJLiYAnFFZhangXChenXLeeCSPreparation and size control of sub-100 nm pure nanodrugsNano Lett201515131331825514014
- ZhangLTianBLiYA copper-mediated disulfiram-loaded pH-triggered PEG-shedding TAT peptide-modified lipid nanocapsules for use in tumor therapyACS Appl Mater Interfaces2015745251472516126501354
- ZhangYWangJBaiXJiangTZhangQWangSMesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugsMol Pharm20129350551322217205
- NiDDingHLiuSSuperior intratumoral penetration of paclitaxel nanodots strengthens tumor restriction and metastasis preventionSmall201511212518252625678130